PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of actaorthLink to Publisher's site
 
Acta Orthop. 2009 October 1; 80(5): 568–572.
Published online 2009 October 1. doi:  10.3109/17453670903350057
PMCID: PMC2823322
Dosimetry during intramedullary nailing of the tibia
Patient and occupational exposure
George Kirousis,1 Harry Delis,2 Panagiotis Megas,1 Elias Lambiris,1 and George Panayiotakiscorresponding author2
1Department of Orthopaedics, School of Medicine, University of Patras, Patras, Greece
2Department of Medical Physics, School of Medicine, University of Patras, Patras, Greece
corresponding authorCorresponding author.
Correspondence: panayiot/at/upatras.gr
Received November 10, 2008; Accepted May 28, 2009.
Abstract
Background Intramedullary nailing under fluoroscopic guidance is a common operation. We studied the intraoperative radiation dose received by both the patient and the personnel.
Patients and methods 25 intramedullary nailing procedures of the tibia were studied. All patients suffered from tibial fractures and were treated using the Grosse-Kempf intramedullary nail, with free-hand technique for fixation of the distal screws, under fluoroscopic guidance. The exposure, at selected positions, was recorded using an ion chamber, while the dose area product (DAP) was measured with a DAP meter, attached to the tube head. Thermoluminescent dosimeters (TLDs) were used to derive the occupational dose to the personnel, and also to monitor the surface dose on the gonads of some of the patients.
Results The mean operation time was 101 (48–240) min, with a mean fluoroscopic time of 72 seconds and a mean DAP value of 75 cGy·cm2. The surface dose to the gonads of the patients was less than 8.8 mGy during any procedure, and thus cannot be considered to be a contraindication for the use of this technique. Occupational dose differed substantially between members of the operating personnel, the maximum dose recorded being to the operator of the fluoroscopic equipment (0.11 mSv).
Interpretation Our findings underscore the care required by the primary operator not to exceed the dose constraint of 10 mSv per year. The rest of the operating personnel, although they do not receive very high doses, should focus on the dose optimization of the technique.
Articles from Acta Orthopaedica are provided here courtesy of
Informa Healthcare